Global Immunohistochemistry (IHC) Market Size, Trends & Growth Opportunity, By Product (Antibodies, Equipments, Reagents and Kits), by Application (Diagnostics and Drug Testing), by End User (Hospitals, Diagnostic Laboratories, Research Institutes, and Others), and By Region and Forecast till 2027.
Report ID : QR1001351 | Industries : Chemicals & Materials | Published On :January 2022 | Page Count : 245Global Immunohistochemistry (IHC) Market
Immunohistochemistry (IHC) is a method of laboratory utilized for checking particular antigens in a sample of tissue by utilizing antibodies. Generally the antibodies bind to a fluorescent dye or an enzyme, that helps researchers see an antigen under a microscope. Immunohistochemistry is utilized widely to diagnose chronic diseases like aids and cancer in differentiating their types. IHC involves specific antigen-antibody reactions, and identify a limited number of proteins, enzymes, and tissue structures as compared to conventional enzyme staining techniques. As a result, it is concluded that an important technique in clinical diagnostics and medical research laboratories to visualize the localization and distribution of particular cellular components under cells.
Drivers:
The growing prevalence of chronic conditions is predicted to drive the Global Immunohistochemistry (IHC) Market. The rising drug consumption, drug development rates, and increasing adoption of outsourcing services are boosting the growth of the market. Medication errors, high spending by the pharmaceutical industry, and the rising cases of adverse drug reactions are also accelerating the growth of pharmacovigilance market.
Know more about this report: request for sample pages
Restraints
However, Pharmacovigilance Market is affected by the government programs and initiatives combined with pharmaceutical companies alertness operations are creating huge influence in spreading dependable information about proper usage of medicines among others. There is also high costs associated with the IHC technology.
Impact of COVID-19
Since the outbreak of covid-19, the disease has spread over 100 countries globally. In December 2019 largely unknown before the outbreak began in Wuhan (China), Covid-19 has moved to global pandemic in just few weeks of origin. On 11th March 2020, WHO declared as global pandemic. The global immunohistochemistry (IHC) market is expected to drive the growth of the market due to the impact of covid-19. Many key players have shifted their focus of business by introducing IHC Products for research of covid-19.
Segmentation By Product
The Global Immunohistochemistry (IHC) Market is segmented on the basis of Product into Antibodies, Equipment, Reagents, and Kits. The antibodies segment is expected yo hold the largest market share of Global Immunohistochemistry (IHC) Market in2020. The kits segment is expected to hold the second largest market share of Global Immunohistochemistry (IHC) Market in 2020. Furthermore, antibodies are essential therapeutic agents and diagnostic in immunology.
Segmentation By Application
The Global Immunohistochemistry (IHC) Market is classified on the basis of Application into diagnostics and drug testing. Diagnostics segment is classified into Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, and Nephrological Diseases. In 2020, the Diagnostic application segment holds the largest market share of Global Immunohistochemistry (IHC) Market. Therefore, IHC has become essential technique and globally utilized for clinical diagnostics and medical research.
Segmentation By End-use:
The Global Immunohistochemistry (IHC) Market is classified on the basis of End-use into Hospitals and Diagnostic Laboratories, Research Institutes, and Others. Hospitals and Diagnostic Laboratories holds the largest market share of Global Immunohistochemistry (IHC) Market in 2020.
Segmentation by Region:
The Global Immunohistochemistry (IHC) Market is classified on the basis of Region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is expected to hold the largest market share of Global Immunohistochemistry (IHC) Market in 2020.
Competitive Landscape:
The key players of Global Immunohistochemistry (IHC) Market are F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Bio-Techne Corporation (US), Abcam plc (UK), Becton, and Dickinson and Company (US).
Market Taxonomy
By Products
- Antibodies
- Equipment
- Reagents
- Kits
By Application:
- Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Drug Testing
By End Use:
- Hospitals and Diagnostic Laboratories
- Research Institutes
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Global Immunohistochemistry (IHC) Market?
- What will be the growth rate from 2020 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
Global Immunohistochemistry (IHC) Market Toc
1. Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2. Research Methodology
2.11 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3. Executive Summary
4. Global Immunohistochemistry (IHC) Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5. Global Immunohistochemistry (IHC) Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Immunohistochemistry (IHC) Market Share Analysis, By Product Type
5.3 Global Immunohistochemistry (IHC) Market Size and Forecast, By Product Type
5.3.1 Antibodies
5.3.2 Equipment
5.3.3 Reagents
5.3.4 Kits
6. Global Immunohistochemistry (IHC) Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Immunohistochemistry (IHC) Market Share Analysis, By Application
6.3 Global Immunohistochemistry (IHC) Market Size and Forecast, By Application
6.3.1 Diagnostics
6.3.1.1 Cancer
6.3.1.2 Infectious Diseases
6.3.1.3 Cardiovascular Diseases
6.3.1.4 Autoimmune Diseases
6.3.1.5 Diabetes Mellitus
6.3.1.6 Nephrological Diseases
6.3.2 Drug Testing
7. Global Immunohistochemistry (IHC) Market, By End-use
7.1 Y-o-Y Growth Comparison, By End-use
7.2 Global Immunohistochemistry (IHC) Market Share Analysis, By End-use
7.3 Global Immunohistochemistry (IHC) Market Size and Forecast, By End-use
7.3.1 Hospitals and Diagnostic Laboratories
7.3.2 Research Institutes
7.3.3 Others
8. Global Immunohistochemistry (IHC) Market, By Geography
8.1 Global Immunohistochemistry (IHC) Market Share Analysis, By Geography
8.2 Global Immunohistochemistry (IHC) Market Size and Forecast, By Geography
9. North America Immunohistochemistry (IHC) Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 North America Immunohistochemistry (IHC) Market Share Analysis, By Product Type
9.3 North America Immunohistochemistry (IHC) Market Size and Forecast, By Application
9.4 North America Immunohistochemistry (IHC) Market Size and Forecast, By End-use
9.5 North America Immunohistochemistry (IHC) Market Size and Forecast, By Country
9.5.1 US
9.5.2 Canada
9.5.3 Mexico
10. Europe Immunohistochemistry (IHC) Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Europe Immunohistochemistry (IHC) Market Share Analysis, By Product
10.3 Europe Immunohistochemistry (IHC) Market Size and Forecast, By Application
10.4 Europe Immunohistochemistry (IHC) Market Size and Forecast, By End-use
10.5 Europe Immunohistochemistry (IHC) Market Size and Forecast, By Country
10.5.1 UK
10.5.2 Germany
10.5.3 France
10.5.4 Rest of Europe (Russia, Spain, Finland, Denmark, Italy, Greece, and Sweden)
11. Asia Pacific Immunohistochemistry (IHC) Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Asia Pacific Immunohistochemistry (IHC) Market Share Analysis, By Product
11.3 Asia Pacific Immunohistochemistry (IHC) Market Size and Forecast, By Application
11.4 Asia Pacific Immunohistochemistry (IHC) Market Size and Forecast, By End-use
11.5 Asia Pacific Immunohistochemistry (IHC) Market Size and Forecast, By Country
11.5.1 China
11.5.2 India
11.5.3 Japan
11.5.4 South Korea
11.2.5 Rest of Asia Pacific (Hong Kong, Australia, Singapore, New Zealand, Indonesia, Malaysia, and Taiwan)
12. Rest of the World Head Mounted Display Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Rest of the World Immunohistochemistry (IHC) Market Share Analysis, By Product
12.3 Rest of the World Immunohistochemistry (IHC) Market Size and Forecast, By Application
12.4 Rest of the World Immunohistochemistry (IHC) Market Size and Forecast, By End-use
12.5 Rest of the World Immunohistochemistry (IHC) Market Size and Forecast, By Country
12.5.1 Middle East & Africa
12.5.2 South America
13. Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14. Company Profiles
14.1 F. Hoffman-La Roche AG (Switzerland)
14.1. Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 Danaher Corporation (US)
14.2.1. Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3. Agilent Technologies, Inc. (US)
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4. Merck KGaA (Germany)
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5. Bio-Rad Laboratories, Inc. (US)
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6. Bio-Techne Corporation (US)
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7. Abcam plc (UK)
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8. Becton
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9. Dickinson and Company (US)
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies